Skip to main content

Media

Latest News

October 17, 2019

WASHINGTON, DC – Congresswoman Jan Schakowsky (IL-9) issued the following statement on news of the passing of her colleague, Congressman Elijah Cummings:


October 16, 2019

WASHINGTON, DC – Congresswoman Jan Schakowsky made the following statement upon passage of the bipartisan, bicameral resolution she supported condemning President Trump's abandonment of the Syrian Kurds:


October 16, 2019

WASHINGTON, DC – Last night, the U.S. House of Representatives passed H.R. 4270, the PROTECT Hong Kong Act; H.R. 3289, the Hong Kong Human Rights and Democracy Act, and H.Res. 543, a resolution supporting the protestors in Hong Kong. Congresswoman Jan Schakowsky made the following statement in response to the passage of these bills she supported:


October 15, 2019

WASHINGTON, DC - Congresswoman Jan Schakowsky, Chair of the House Committee on Energy and Commerce Consumer Protection and Commerce Subcommittee, Congressman John Sarbanes, and Congresswoman Debbie Dingell released a statement on H.R. 3, the Lower Drug Costs Now Act, in advance of the Committee's markup of the legislation:

"Today, we are announcing our endorsement of H.R. 3, a pillar of the Democratic Caucus' For the People agenda and a bill that will significantly lower drug prices for patients who need them to survive.

Issues:Health

October 10, 2019

EVANSTON, IL – Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chairwoman of the Consumer Protection and Commerce Subcommittee, made the following statement today on news of the retirement of her colleague Congresswoman Nita Lowey, Chairwoman of the House Appropriations Committee.


October 8, 2019

WASHINGTON, DC – Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chairwoman of the Consumer Protection and Commerce Subcommittee of the House Committee on Energy and Commerce, was joined by Representatives Brian Higgins (D-NY) and Susan Wild (D-PA) to introduce H.R. 4619, the Pharmaceutical Rebates for Excessive Pricing Above Inflation (REPAI) Act. This legislation will impose a new inflation rebate for the thousands of drugs that older Americans rely on and access through Medicare Part D.


September 26, 2019

WASHINGTON, DC - Yesterday, Congresswoman Schakowsky, Senior Chief Deputy Whip and Chair of the Energy and Commerce Subcommittee on Consumer Protection and Commerce, delivered opening remarks at the Energy and Commerce Health Subcommittee hearing on "Making Prescription Drugs More Affordable: Legislation to Negotiate a Better Deal for Americans." Her statement as prepared for delivery is below:

Issues:Health

September 24, 2019

WASHINGTON, DC - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip, issued the following statement:

"Today, Speaker of the House Nancy Pelosi announced that the House of Representatives will move forward an official impeachment investigation into this President's abuses of power. I am fully supportive of this effort and will not stop fighting until this President is held accountable, our elections are secure, and faith in our democracy is restored.


September 20, 2019

WASHINGTON, DC – Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip, and chair of the Consumer Protection and Commerce Subcommittee of the House Energy and Commerce Committee, voted to restore access to the courts for millions of American consumers and employees, who are currently locked into a forced arbitration system that favors corporations. H.R. 1423, the Forced Arbitration Injustice Repeal Act, passed the U.S. House by a vote of 225-186.


September 19, 2019

WASHINGTON, DC – Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip, chaired a hearing in her Consumer Protection and Commerce Subcommittee of the House Energy and Commerce Committee, entitled "Profits Over Consumers: Exposing How Pharmaceutical Companies Game the System."

"I presided over a hearing today in the Committee on Energy and Commerce's Subcommittee on Consumer Protection and Commerce that shined a light on the many ways Big Pharma uses various tactics to game the system, thus allowing them to price gouge consumers.

Issues:Health